D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain

The EMBO Journal
B GanterJ S Lipsick

Abstract

The v-Myb DNA-binding domain differs from that of c-Myb mainly by deletion of the first of three repeats. This truncation correlates with efficient oncogenic transformation and a decrease in DNA-binding activity. Here we demonstrate that the D-type cyclins, cyclin D1 and D2 in particular, specifically inhibit transcription when activated through the v-Myb DNA-binding domain, but not the c-Myb DNA-binding domain. Analysis of a cyclin D1 mutant and a dominant-negative CDK4 mutant implied that this repression is independent of complex formation with a CDK partner. Association of cyclin D1 and D2 with the Myb DNA-binding domain could be demonstrated. Increased levels of cyclin D1 and D2 resulted in a stabilization of the Myb proteins, but not in an alteration in binding of the Myb proteins to DNA. These results highlight an unexpected role for cyclin D as a CDK-independent repressor of transcriptional activation by v-Myb but not c-Myb. This differential effect of D-type cyclins on v-Myb and c-Myb might help to explain the mechanism underlying the oncogenic activity of v-Myb, which appears to be a stronger transcriptional activator following the TPA-induced differentiation of transformed monoblasts when cyclin D1 and D2 are down-reg...Continue Reading

References

Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S P Duprey, D Boettiger
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J C ReedR G Hoover
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·W J BoyleM A Baluda
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·E H WestinF Wong-Staal
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·G A KassavetisM Pisano
Jul 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·N AzizT P Bender
Jun 1, 1995·Genes & Development·R L BeijersbergenR Bernards
Apr 25, 1994·Nucleic Acids Research·H E FeilotterD Beach
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·P W HindsR A Weinberg
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J TanikawaA Sarai
Sep 1, 1996·Genes & Development·W WangG R Crabtree
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·A SalaC Peschle
Feb 20, 1997·Nature·B van Steensel, T de Lange
Feb 7, 1997·Cell·R M ZwijsenR J Michalides
Apr 1, 1997·Current Biology : CB·U ZieboldK H Klempnauer
Jul 10, 1997·Oncogene·B Ganter, J S Lipsick

❮ Previous
Next ❯

Citations

Dec 3, 2002·Gene·Olivier Coqueret
Apr 4, 2006·Nature Immunology·A Byron CooperIannis Aifantis
Jan 24, 2007·Oncogene·K InoueD P Frazier
Dec 18, 2007·Oncogene·N A OlshavskyK E Knudsen
Jan 7, 2009·The Journal of Biological Chemistry·Tao ZhangMichael S Lan
Jun 14, 2003·Journal of Hematotherapy & Stem Cell Research·Alice NemajerováJana Smardová
Jun 8, 2001·Anti-cancer Drugs· Wakita KiK Akahane
Apr 25, 2007·Molecular and Cellular Biology·Etsuo SusakiKeiichi I Nakayama
Aug 15, 2003·Molecular and Cellular Biology·Chenguang WangRichard G Pestell
Feb 18, 2003·Molecular and Cellular Biology·J Alan DiehlAndrew Emili
Nov 17, 2005·Molecular and Cellular Biology·Luke F PetersonDong-Er Zhang
Jul 26, 2006·Cell Division·Karen E Knudsen
Oct 30, 2004·Genetics·Jan EmmerichChristian F Lehner
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Ye Zhou, Scott A Ness
Dec 19, 2000·Biochemical and Biophysical Research Communications·M S ChangY C Yang
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·E GrotewoldV L Chandler
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Fabienne VailleauDominique Roby
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·C McMahonM E Ewen
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·K InoueC J Sherr
Jun 26, 2001·International Journal of Experimental Pathology·C Swanton, N Jones
Nov 19, 2013·Leukemia & Lymphoma·Stefan NagelRoderick A F MacLeod
Sep 14, 2004·The Plant Journal : for Cell and Molecular Biology·Ilona M ZimmermannJoachim F Uhrig
Jun 7, 2005·Chemico-biological Interactions·Joanne WanLouise Winn
Apr 17, 2016·International Journal of Hematology·Sha HaoTao Cheng
Sep 11, 2004·Biochemical and Biophysical Research Communications·Wenjin LiuJianxin Gu
Feb 21, 2007·Differentiation; Research in Biological Diversity·Jarmila NavrátilováJan Smarda
Oct 25, 2016·Nature Chemical Biology·Fuun KawanoMoritoshi Sato
Apr 28, 2000·International Immunology·N SolvasonE Lees
Nov 29, 2002·The Journal of Biological Chemistry·Kristin Brevik AnderssonOdd S Gabrielsen
Jan 1, 2015·Signal Transduction Insights·Kazushi Inoue, Elizabeth A Fry
Sep 27, 2007·Journal of Cellular Physiology·Anthony ScimèPeter Whyte
Jun 23, 1999·Oncogene·J S Lipsick, D M Wang
Feb 20, 2004·Oncogene·Stephan SchubertKarl-Heinz Klempnauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.